Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Neurol Clin. 2009 Nov;27(4):941. doi: 10.1016/j.ncl.2009.08.005

Box 1.

Clinical manifestations of polycystic ovarian syndrome

Signs and symptoms (proportion of patients affected)
 Obesity (38%)
 Menstrual disturbance (66%)
  Oligomenorrhea (47%)
  Amenorrhea (19%)
  [Regular cycle 30%]
 Hyperandrogenism (48%)
 Infertility (73% of anovulatory infertility)
 Symptomless–20% of those with polycystic ovaries
Hormone systems that might be disturbed
 Insulin ↑
 Sex-hormone-binding globulin ↓
 Androgens (testosterone and androstenedione) ↑
 Luteinizing hormone ↑
 Prolactin ↑
Possible late sequelae
 Dyslipidemia
  Low-density lipoprotein (LDL) ↑, High-density lipoprotein (HDL) ↓
  Triglycerides ↑
 Diabetes mellitus
 Cardiovascular disease; hypertension
 Endometrial carcinoma

Data from Balen A. Pathogenesis of polycystic ovary syndrome—the enigma unravels? Lancet 999;354:966.